TeamDrive
RUS

Chile interested in expanding cooperation with St. Petersburg Research Institute

13 September 2017

GMP News

A meeting between the representatives of Instituto de Salud Pública, Chile, and St. Petersburg Research Institute of Vaccines and Serums was held in St. Petersburg.

The Chilean side represented by Pablo Ortiz Diaz, the Managing Finance Director, showed interest in expanding the cooperation with St. Petersburg Research Institute of Vaccines and Serums in assessing the potential for the presence of Russian immunobiological products in the market of Chile and other countries of the region. At the meeting, the parties agreed to sign a framework agreement on cooperation, which would include organizing the supplies of immunobiological products, joint research and development, as well as the creation of talent pool in the area of biotechnology.

“This meeting with Chilean colleagues is an important step in the development of relations both between our countries and across the Latin America. Chile pursues a consistent policy for prevention of viral diseases in population of the country, and the authorities are closely monitoring the implementation of the National Immunization Program and selection of required drugs,” said Stanislav Uiba, the Director General of MECHNIKOV Latin American Biotechnology Institute, after the meeting.

The competencies of Instituto de Salud Pública are especially important for the Russian side because of the project for construction of MECHNIKOV Latin American Biotechnology Institute implemented by St. Petersburg Research Institute of Vaccines and Serums in Nicaragua. Among other things, the activities of the Institute will be aimed at combating dangerous and rare viral diseases in Latin America and the Caribbean.

Source


Previous publication Next publication

Media Center

  • 25 September 2017

    Russian University creates a bank of biomolecules for new drugs

    The research activities of Genomic and Regenerative Medicine Center established at the School of Biomedicine in the Far Eastern Federal University (FEFU) will be based on unique natural resources of the Russian Far East. The scientists will study the biodiversity of the region, including marine organisms, create a bank of biomolecules for new drugs, and introduce innovative diagnostic and treatment methods into routine medical practice.

  • 25 September 2017

    Transition to multicomponent preventive drugs is necessary

    During the second BIOTECHMED conference held in Gelendzhik, the representatives of Nacimbio, a company which is part of Rostec Corporation, participated in panel discussions on preventive vaccination and expansion of the National Immunization Calendar.

  • 22 September 2017

    SPIC’s will ensure more predictability for pharmaceutical companies in Russia

    A meeting of the working group of the Coordination Council in the Area of Circulation of Medicines and Medical Devices held in the Russian Union of Industrialists and Entrepreneurs (RSPP) examined the state and development prospects of manufacturing the drugs for the treatment of oncological diseases in Russia.

  • 22 September 2017

    Cancer biobank Indivumed and CRO Helomics team up on precision medicine

    Indivumed, which has a large cancer biobank, has partnered with cancer research specialist Helomics to analyze human cancer biospecimens and relevant clinical datIndivumed, which has a large cancer biobank, has partnered with cancer research specialist Helomics to analyze human cancer biospecimens and relevant clinical data collected from patients around the world to help advance research in personalized cancer treatments. collected from patients around the world to help advance research in personalized cancer treatments.

Read more